Sort
21,281 grants matching “influenza”
Role of T Regulatory Cells in Chronic Infection
$457,509Ethan Shevach · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
CVD INFLUENZA 6000
$457,503James D Campbell · University Of Maryland Baltimore · M01 · FY2006 · RR
Role of a Novel Interferon Responsive T Cell Subset in Allergy and Asthma
$457,500Gregory Seumois · La Jolla Institute For Immunology · R01 · FY2022 · AI
Role of a Novel Interferon Responsive T Cell Subset in Allergy and Asthma
$457,500Gregory Seumois · La Jolla Institute For Immunology · R01 · FY2023 · AI
Evaluating Modes of Influenza Transmission using a Randomized Controlled Trial (EMIT-2-RCT)
$457,430Donald K Milton · Univ Of Maryland, College Park · U19 · FY2021 · AI
Impact of Infections on the Stability of Established Tolerance
$457,402Anita S. Chong · University Of Chicago · P01 · FY2015 · AI
Novel exosomal niches for alveolar stem cell-bassed repair of ARDS
$457,366Hong-Long Ji · Loyola University Chicago · R01 · FY2024 · HL
Administrative and Clinical Core
$457,325Katherine F Luzuriaga · Univ Of Massachusetts Med Sch Worcester · P01 · FY2014 · AI
Administrative and Clinical Core
$457,325Katherine F Luzuriaga · Univ Of Massachusetts Med Sch Worcester · P01 · FY2016 · AI
B-1 cells, IgM and Protective Humoral Immunity to Influenza
$457,282Nicole Baumgarth · University Of California At Davis · R01 · FY2019 · AI
Proteomic networks of MUC5B infectious/inflammatory induction in Otitis Media
$457,054Diego Preciado · Children'S Research Institute · R01 · FY2012 · DC
Advanced Microarray Technology for Pathogen Surveillance
$457,039Kathy L Rowlen · Indevr, Inc. · U01 · FY2010 · AI
The Rochester Center for Mind-Body Research
$457,002Jan A Moynihan · University Of Rochester · R21 · FY2006 · AG
Systems investigation of vaccine responses in B cell depleted autoimmune patients
$456,987David A. Hafler · Yale University · U19 · FY2025 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$456,982John Jay Treanor · University Of Rochester · N01 · FY2020 · AI
AVIAN INFLUENZA VIRUS (AIV) IS A DEVASTATING DISEASEWITH DEMONSTRATED ABILITY TO CAUSE THE LOSS OF HUNDREDS OF MILLIONS OF BIRDS.THE MAJOR GOAL OF THIS PROJECT IS TOTEST THE HYPOTHESIS THAT MODIFIED LIVE VIRUS (MLV) VACCINESINDUCE GREATER AND MORE BROADLY REACTIVE IMMUNE RESPONSES AND PROVIDE SUPERIOR PROTECTION THAN STANDARD INACTIVATED VACCINES AGAINST AVIAN INFLUENZA.THE POULTRY INDUSTRY, COMPRISING OF BILLIONS OF BIRDS, IS OF HUGE ECONOMIC AND SOCIAL IMPORTANCE THROUGHOUT THE WORLD. IN SOME COUNTRIES, VACCINATION HAS BEEN INTRODUCED TO PREVENT AIV OUTBREAKS; HOWEVER,CURRENT VACCINES OFFERLIMITED PROTECTION AND CANNOT PREVENT THE SPREAD OF THE VIRUS. NOWADAYS, THE WORLD CONFRONTS ANUNPRECEDENTED SPREAD OFAIVS IN POULTRY INASIA, THE MIDDLE EAST AND AFRICA, WITH FREQUENT SPILL OVER ANDTRANSCONTINENTAL SPREAD OF THESE VIRUSES THROUGH MIGRATORY BIRDS TO OTHER PARTS OF THE WORLD, INCLUDING THE U.S. THUS, IT IS ABSOLUTELY ESSENTIALTO BETTER UNDERSTANDTHE MECHANISMS INVOLVED IN VACCINE IMMUNOGENICITY AND TODEVELOPALTERNATIVE VACCINATION STRATEGIES THAT CAN MORE EFFECTIVELY CONTRIBUTE TO PREVENT AND CONTROL OF AIV.WE ARE A STRONG COLLABORATIVE TEAM WITH EXPERTISE IN INFLUENZA VIRUS REVERSE GENETICS, AVIAN IMMUNOLOGY AND AVIAN MODELS OF INFLUENZA DISEASE TO DEVELOP MLV VACCINES AGAINSTAIVS FOR USE IN POULTRY. WE WILL COMPARE THE CHARACTERISTICS OF MLV VACCINESIN VITROANDIN VIVOAND EXAMINE SAFETY,TRANSMISSION POTENTIAL OF THE VACCINES TO SUSCEPTIBLE BIRDS, AND GENETIC VARIABILITY OF CHALLENGE VIRUSOUT OF VACCINATED VERSUS NON-VACCINATEDBIRDS.
$456,934University Of Georgia Research Foundation, Inc. · · FY2020 · National Institute of Food and Agriculture
Human CD8+ and CD4+ T Cells Responses to Influenza Infection and Vaccination
$456,874Masanori Terajima · Univ Of Massachusetts Med Sch Worcester · U19 · FY2009 · AI
Determinants of H. influenzae Virulence in Otitis Media
$456,860Lauren O Bakaletz · Research Inst Nationwide Children'S Hosp · R01 · FY2016 · DC
Use of DNATrax and high fidelity computational methods to model transport of contaminants in urban environments
$456,730Nicholas J Heredia · Safetraces, Inc. · R44 · FY2019 · ES
Respiratory mucosal immune development in early life and the quest for protective local memory against respiratory syncytial virus.
$456,726Allison Marie Wahl Malloy · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2020 · AI
Context dependent amino acid availability and sensing determines humoral immunity
$456,703Hu Zeng · Mayo Clinic Rochester · R01 · FY2025 · AI
Service Core C - Immune Monitoring
$456,673Gregory D Sempowski · Duke University · U19 · FY2016 · AI
Disease Modeling of Influenza and Other Emerging Respiratory Viral Pathogens
$456,404Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Impact of aging on naive CD4 T cell function
$456,219Susan L Swain · Univ Of Massachusetts Med Sch Worcester · R37 · FY2010 · AG
IMPACT OF CMV UPON T-CELL AGING AND IMMUNE DEFENSE
$456,185Janko Nikolich-Zugich · University Of Arizona · R01 · FY2016 · AG